Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 nov. 2018 11h14 HE | Source: Chembio Diagnostics, Inc.

Chembio Ebola Virus Diagnostic Test Receives U.S. FDA Emergency Use Authorization

MEDFORD, N.Y., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care ("POC") diagnostics company focused on infectious diseases, today announced the...
09 nov. 2018 08h00 HE | Source: Chembio Diagnostics, Inc.

Chembio to Participate in Upcoming Investor Conferences

MEDFORD, N.Y., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced plans to participate in...
08 nov. 2018 16h18 HE | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Third Quarter 2018 Financial Results

MEDFORD, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
01 nov. 2018 07h00 HE | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock

MEDFORD, N.Y., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today the...
31 oct. 2018 16h05 HE | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Proposed Public Offering of Common Stock

MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today that it...
31 oct. 2018 08h00 HE | Source: Chembio Diagnostics, Inc.

Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018

MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
25 oct. 2018 08h00 HE | Source: Chembio Diagnostics, Inc.

Chembio Determines Not to Proceed with Proposed Public Offering of Common Stock

MEDFORD, N.Y., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) today announced that it has determined not to proceed with the proposed public offering of $25 million of...
22 oct. 2018 17h27 HE | Source: Chembio Diagnostics, Inc.

Chembio Announces Proposed Public Offering of Common Stock

MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care diagnostics company focused on infectious diseases,...
22 oct. 2018 16h38 HE | Source: Chembio Diagnostics, Inc.

Chembio Reports Preliminary Third Quarter 2018 Revenue

Signs Definitive Agreement to Acquire opTricon GmbH MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care...
16 oct. 2018 07h00 HE | Source: Chembio Diagnostics, Inc.

Chembio Receives $10.5 Million Commitment from Bio-Manguinhos for Production of DPP® Assays in Brazil

MEDFORD, N.Y., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has...

Page précédente